Julius Elmore, MD
Cardiovascular Disease · Macon, GANPI 1457523367
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Boston Scientific at 38.3% of the total. 2025 is the largest year on record at $24,718, 3.2 times the $7,704 reported in 2019. Among cardiovascular disease clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 479 payments — averaging $114.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$21K
- Medtronic$20K
- Philips North America LLC$4K
- Edwards Lifesciences$3K
- Angiodynamics, Inc.$2K
- Abbott$1K
- plus $4K from 28 others
Across 1 payment — averaging $45,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$45K
What the payments were for
- Speaking & faculty fees$28,23151%
- Travel & lodging$10,79220%
- Food & beverage$15,83729%
- Education$570%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 66 | $21,049 |
| Medtronic(2 entities) | 124 | $19,776 |
| Philips North America LLC | 16 | $4,159 |
| Edwards Lifesciences | 72 | $2,955 |
| Angiodynamics, Inc. | 5 | $1,824 |
| Abbott | 15 | $1,111 |
| Johnson & Johnson | 36 | $578 |
| Novartis | 30 | $443 |
| Pfizer | 21 | $332 |
| Teleflex LLC | 6 | $300 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $289 |
| Amgen | 10 | $257 |
| Bayer | 9 | $186 |
| AstraZeneca | 12 | $182 |
| Heartflow, Inc. | 1 | $180 |
| Abiomed | 3 | $167 |
| Merck | 7 | $156 |
| E.r. Squibb & Sons, L.L.C. | 6 | $144 |
| Recor Medical Inc | 1 | $124 |
| Arrow International, Inc. | 1 | $121 |
| Kestra Medical Technology Services, Inc. | 1 | $104 |
| Inspire Medical Systems, Inc. | 1 | $93 |
| Bridgebio Pharma, Inc. | 3 | $65 |
| Esperion Therapeutics, Inc. | 4 | $56 |
| Chiesi USA, Inc. | 3 | $55 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Scpharmaceuticals Inc. | 2 | $36 |
| Actelion Pharmaceuticals US, Inc. | 2 | $35 |
| Cardiovascular Systems Inc. | 1 | $28 |
| Cardinal Health 200 LLC | 1 | $18 |
| Shockwave Medical, Inc | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Osprey Medical Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$17,771
- CoreValve Evolut$16,380
- (9520) IGT Devices Undivided$2,585
- COREVALVE EVOLUT R$1,214
- WATCHMAN Access System$1,214
- SAPIEN 3 Ultra RESILIA$983
- (BQ9) Coronary IVUS$634
- Edwards SAPIEN 3 Transcatheter Heart Valve$378
- WATCHMAN FLX$296
- (6571) Eagle Eye$251
- AMPLATZER Occluders$248
- MitraClip System$247
- TURNPIKE$227
- FFRct$180
- ONYX FRONTIER$160
- Avalus$150
- GENERAL - STRUCTURAL HEART$145
- Impella$134
- MANTA$133
- 3F$127
How this compares
$54,918 in reported general payments places this provider in the 95th percentile of 640 cardiovascular disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 252 | $312,452 |
| EliquisApixaban | 310 | $293,754 |
| XareltoRivaroxaban | 78 | $76,007 |
| FarxigaDapagliflozin Propanediol | 53 | $57,777 |
| BrilintaTicagrelor | 37 | $33,752 |
| Repatha SureclickEvolocumab | 32 | $31,291 |
| NexlizetBempedoic Acid/Ezetimibe | 38 | $22,747 |
| Metoprolol Succinate | 766 | $11,715 |
| Ranolazine ErRanolazine | 77 | $8,046 |
| Atorvastatin Calcium | 590 | $5,377 |
| Midodrine Hcl | 77 | $4,765 |
| Losartan Potassium | 534 | $4,465 |
| EdarbyclorAzilsartan Med/Chlorthalidone | 14 | $3,442 |
| ClopidogrelClopidogrel Bisulfate | 309 | $3,327 |
| Pyridostigmine Bromide | 104 | $3,227 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $443 | $312,452252 claims |
| PfizerEliquis | $332 | $293,754310 claims |
| AstraZenecaFarxiga, Brilinta | $182 | $91,52990 claims |
| Johnson & JohnsonXarelto | $578 | $76,00778 claims |
| Esperion Therapeutics, Inc.Nexlizet | $56 | $22,74738 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 640 cardiovascular disease providers in Georgia.
Other cardiovascular disease in Macon
- Erskine JamesMacon$67K
- William KnopfMacon$43K
- Onajefe Nelson-TwakorMacon$23K
- Amy KingmanMacon$21K
- Narendra SinghJohns Creek$1.6M
- Hunter ChampionColumbus$1.5M
- Nicolas ChronosEatonton$912K
- Jaime BurkleGainesville$628K
- Joseph MillerAtlanta$573K
- Kashyap ChoksiThomasville$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.